{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:34:59Z","timestamp":1791408899534,"version":"4.3.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,25]],"date-time":"2015-08-25T00:00:00Z","timestamp":1440460800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s13365-015-0374-7","type":"journal-article","created":{"date-parts":[[2015,8,24]],"date-time":"2015-08-24T17:41:48Z","timestamp":1440438108000},"page":"104-113","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trial"],"prefix":"10.1007","volume":"22","author":[{"name":"For the EARNEST Trial Team","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3368-5005","authenticated-orcid":false,"given":"Alejandro","family":"Arenas-Pinto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godfrey","family":"Musoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hellen","family":"Musana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Lugemwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Kambugu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aggrey","family":"Mweemba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dickens","family":"Atwongyeire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret J.","family":"Thomason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Sarah","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas I.","family":"Paton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,25]]},"reference":[{"issue":"2","key":"374_CR1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/135965350801300203","volume":"13","author":"A Arenas-Pinto","year":"2008","unstructured":"Arenas-Pinto A, Bhaskaran K, Dunn D, Weller IV (2008) The risk of developing peripheral neuropathy induced by nucleoside reverse transcriptase inhibitors decreases over time: evidence from the Delta trial. Antivir Ther 13(2):289\u2013295","journal-title":"Antivir Ther"},{"issue":"2","key":"374_CR2","first-page":"88","volume":"9","author":"J Biraguma","year":"2012","unstructured":"Biraguma J, Rhoda A (2012) Peripheral neuropathy and quality of life of adults living with HIV\/AIDS in the Rulindo district of Rwanda. SAHARA J 9(2):88\u201394","journal-title":"SAHARA J"},{"issue":"9","key":"374_CR3","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/thx.2006.058867","volume":"61","author":"RA Breen","year":"2006","unstructured":"Breen RA, Miller RF, Gorsuch T, Smith CJ, Schwenk A, Holmes W et al (2006) Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection. Thorax 61(9):791\u2013794","journal-title":"Thorax"},{"issue":"12","key":"374_CR4","doi-asserted-by":"crossref","first-page":"e14256","DOI":"10.1371\/journal.pone.0014256","volume":"5","author":"D Cettomai","year":"2010","unstructured":"Cettomai D, Kwasa J, Kendi C, Birbeck GL, Price RW, Bukusi EA et al (2010) Utility of quantitative sensory testing and screening tools in identifying HIV-associated peripheral neuropathy in Western Kenya: pilot testing. PLoS One 5(12):e14256","journal-title":"PLoS One"},{"issue":"6","key":"374_CR5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s13365-013-0216-4","volume":"19","author":"H Chen","year":"2013","unstructured":"Chen H, Clifford DB, Deng L, Wu K, Lee AJ, Bosch RJ et al (2013) Peripheral neuropathy in ART-experienced patients: prevalence and risk factors. J Neurovirol 19(6):557\u2013564","journal-title":"J Neurovirol"},{"issue":"4","key":"374_CR6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1212\/WNL.0b013e3181af7a22","volume":"73","author":"CL Cherry","year":"2009","unstructured":"Cherry CL, Affandi JS, Imran D, Yunihastuti E, Smyth K, Vanar S et al (2009) Age and height predict neuropathy risk in patients with HIV prescribed stavudine. Neurology 73(4):315\u2013320","journal-title":"Neurology"},{"issue":"3","key":"374_CR7","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1212\/WNL.52.3.607","volume":"52","author":"EA Childs","year":"1999","unstructured":"Childs EA, Lyles RH, Selnes OA, Chen B, Miller EN, Cohen BA et al (1999) Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 52(3):607\u2013613","journal-title":"Neurology"},{"issue":"6","key":"374_CR8","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/00001756-200004270-00015","volume":"11","author":"MA Collins","year":"2000","unstructured":"Collins MA, Neafsey EJ, Zou JY (2000) HIV-I gpI20 neurotoxicity in brain cultures is prevented by moderate ethanol pretreatment. Neuroreport 11(6):1219\u20131222","journal-title":"Neuroreport"},{"issue":"1","key":"374_CR9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00002030-200201040-00010","volume":"16","author":"GL Dean","year":"2002","unstructured":"Dean GL, Edwards SG, Ives NJ, Matthews G, Fox EF, Navaratne L et al (2002) Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS 16(1):75\u201383","journal-title":"AIDS"},{"issue":"6","key":"374_CR10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/13550280500384966","volume":"11","author":"RJ Ellis","year":"2005","unstructured":"Ellis RJ, Evans SR, Clifford DB, Moo LR, McArthur JC, Collier AC et al (2005) Clinical validation of the NeuroScreen. J Neurovirol 11(6):503\u2013511","journal-title":"J Neurovirol"},{"issue":"5","key":"374_CR11","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ana.21484","volume":"64","author":"RJ Ellis","year":"2008","unstructured":"Ellis RJ, Marquie-Beck J, Delaney P, Alexander T, Clifford DB, McArthur JC et al (2008) Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy. Ann Neurol 64(5):566\u2013572","journal-title":"Ann Neurol"},{"issue":"5","key":"374_CR12","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/archneurol.2010.76","volume":"67","author":"RJ Ellis","year":"2010","unstructured":"Ellis RJ, Rosario D, Clifford DB, McArthur JC, Simpson D, Alexander T et al (2010) Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. Arch Neurol 67(5):552\u2013558","journal-title":"Arch Neurol"},{"issue":"7","key":"374_CR13","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/QAD.0b013e328345889d","volume":"25","author":"SR Evans","year":"2011","unstructured":"Evans SR, Ellis RJ, Chen H, Yeh TM, Lee AJ, Schifitto G et al (2011) Peripheral neuropathy in HIV: prevalence and risk factors. AIDS 25(7):919\u2013928","journal-title":"AIDS"},{"issue":"3","key":"374_CR14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s13365-012-0093-2","volume":"18","author":"D Evans","year":"2012","unstructured":"Evans D, Takuva S, Rassool M, Firnhaber C, Maskew M (2012) Prevalence of peripheral neuropathy in antiretroviral therapy naive HIV-positive patients and the impact on treatment outcomes\u2014a retrospective study from a large urban cohort in Johannesburg, South Africa. J Neurovirol 18(3):162\u2013171","journal-title":"J Neurovirol"},{"issue":"Suppl 5","key":"374_CR15","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/01.aids.0000391019.10661.66","volume":"24","author":"AD Grant","year":"2010","unstructured":"Grant AD, Mngadi KT, van Halsema CL, Luttig MM, Fielding KL, Churchyard GJ (2010) Adverse events with isoniazid preventive therapy: experience from a large trial. AIDS 24(Suppl 5):S29\u201336","journal-title":"AIDS"},{"issue":"3","key":"374_CR16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s11916-012-0257-z","volume":"16","author":"PR Kamerman","year":"2012","unstructured":"Kamerman PR, Wadley AL, Cherry CL (2012) HIV-associated sensory neuropathy: risk factors and genetics. Curr Pain Headache Rep 16(3):226\u2013236","journal-title":"Curr Pain Headache Rep"},{"issue":"5","key":"374_CR17","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/QAI.0b013e3182968ea5","volume":"63","author":"E Kampira","year":"2013","unstructured":"Kampira E, Kumwenda J, van Oosterhout JJ, Dandara C (2013) Mitochondrial DNA subhaplogroups L0a2 and L2a modify susceptibility to peripheral neuropathy in malawian adults on stavudine containing highly active antiretroviral therapy. J Acquir Immune Defic Syndr 63(5):647\u2013652","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"374_CR18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1086\/426076","volume":"40","author":"KA Lichtenstein","year":"2005","unstructured":"Lichtenstein KA, Armon C, Baron A, Moorman AC, Wood KC, Holmberg SD (2005) Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort. Clin Infect Dis 40(1):148\u2013157","journal-title":"Clin Infect Dis"},{"issue":"1","key":"374_CR19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1742-6405-9-35","volume":"9","author":"HN Luma","year":"2012","unstructured":"Luma HN, Tchaleu BC, Doualla MS, Temfack E, Sopouassi VN, Mapoure YN et al (2012) HIV-associated sensory neuropathy in HIV-1 infected patients at the Douala General Hospital in Cameroon: a cross-sectional study. AIDS Res Ther 9(1):35","journal-title":"AIDS Res Ther"},{"issue":"5","key":"374_CR20","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/mus.21535","volume":"41","author":"J Maritz","year":"2010","unstructured":"Maritz J, Benatar M, Dave JA, Harrison TB, Badri M, Levitt NS et al (2010) HIV neuropathy in South Africans: frequency, characteristics, and risk factors. Muscle Nerve 41(5):599\u2013606","journal-title":"Muscle Nerve"},{"issue":"6","key":"374_CR21","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1212\/WNL.51.6.1678","volume":"51","author":"CM Marra","year":"1998","unstructured":"Marra CM, Boutin P, Collier AC (1998) Screening for distal sensory peripheral neuropathy in HIV-infected persons in research and clinical settings. Neurology 51(6):1678\u20131681","journal-title":"Neurology"},{"issue":"5","key":"374_CR22","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/cid\/cir432","volume":"53","author":"SA Mehta","year":"2011","unstructured":"Mehta SA, Ahmed A, Laverty M, Holzman RS, Valentine F, Sivapalasingam S (2011) Sex differences in the incidence of peripheral neuropathy among Kenyans initiating antiretroviral therapy. Clin Infect Dis 53(5):490\u2013496","journal-title":"Clin Infect Dis"},{"issue":"7","key":"374_CR23","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1089\/aid.2009.0276","volume":"26","author":"BK Nakamoto","year":"2010","unstructured":"Nakamoto BK, McMurtray A, Davis J, Valcour V, Watters MR, Shiramizu B et al (2010) Incident neuropathy in HIV-infected patients on HAART. AIDS Res Hum Retrovir 26(7):759\u2013765","journal-title":"AIDS Res Hum Retrovir"},{"issue":"3","key":"374_CR24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.beem.2011.04.003","volume":"25","author":"IJ Paik","year":"2011","unstructured":"Paik IJ, Kotler DP (2011) The prevalence and pathogenesis of diabetes mellitus in treated HIV-infection. Best Pract Res Clin Endocrinol Metab 25(3):469\u2013478","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"374_CR25","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1056\/NEJMoa1311274","volume":"371","author":"NI Paton","year":"2014","unstructured":"Paton NI, Kityo C, Hoppe A, Reid A, Kambugu A, Lugemwa A et al (2014) Assessment of second-line antiretroviral regimens for HIV therapy in Africa. N Engl J Med 371(3):234\u2013247","journal-title":"N Engl J Med"},{"issue":"5","key":"374_CR26","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/ana.20816","volume":"59","author":"JA Pettersen","year":"2006","unstructured":"Pettersen JA, Jones G, Worthington C, Krentz HB, Keppler OT, Hoke A et al (2006) Sensory neuropathy in human immunodeficiency virus\/acquired immunodeficiency syndrome patients: protease inhibitor-mediated neurotoxicity. Ann Neurol 59(5):816\u2013824","journal-title":"Ann Neurol"},{"issue":"5","key":"374_CR27","doi-asserted-by":"crossref","first-page":"e63986","DOI":"10.1371\/journal.pone.0063986","volume":"8","author":"A Shaikh","year":"2013","unstructured":"Shaikh A, Bentley A, Kamerman PR (2013) Symptomatology of peripheral neuropathy in an African language. PLoS One 8(5):e63986","journal-title":"PLoS One"},{"issue":"6","key":"374_CR28","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R","volume":"18","author":"S Buuren van","year":"1999","unstructured":"van Buuren S, Boshuizen HC, Knook DL (1999) Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 18(6):681\u2013694","journal-title":"Stat Med"},{"issue":"6","key":"374_CR29","doi-asserted-by":"crossref","first-page":"722","DOI":"10.5588\/ijtld.10.0284","volume":"15","author":"JJ Watt van der","year":"2011","unstructured":"van der Watt JJ, Harrison TB, Benatar M, Heckmann JM (2011) Polyneuropathy, anti-tuberculosis treatment and the role of pyridoxine in the HIV\/AIDS era: a systematic review. Int J Tuberc Lung Dis 15(6):722\u2013728","journal-title":"Int J Tuberc Lung Dis"},{"issue":"7","key":"374_CR30","doi-asserted-by":"crossref","first-page":"e42029","DOI":"10.1371\/journal.pone.0042029","volume":"7","author":"JJ Oosterhout van","year":"2012","unstructured":"van Oosterhout JJ, Mallewa J, Kaunda S, Chagoma N, Njalale Y, Kampira E et al (2012) Stavudine toxicity in adult longer-term ART patients in Blantyre, Malawi. PLoS One 7(7):e42029","journal-title":"PLoS One"},{"issue":"4","key":"374_CR31","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jpainsymman.2010.07.006","volume":"41","author":"AL Wadley","year":"2011","unstructured":"Wadley AL, Cherry CL, Price P, Kamerman PR (2011) HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans. J Pain Symptom Manag 41(4):700\u2013706","journal-title":"J Pain Symptom Manag"},{"issue":"11","key":"374_CR32","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1086\/598977","volume":"48","author":"DJ Westreich","year":"2009","unstructured":"Westreich DJ, Sanne I, Maskew M, Malope-Kgokong B, Conradie F, Majuba P et al (2009) Tuberculosis treatment and risk of stavudine substitution in first-line antiretroviral therapy. Clin Infect Dis 48(11):1617\u20131623","journal-title":"Clin Infect Dis"},{"issue":"1","key":"374_CR33","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1212\/01.wnl.0000316390.17248.65","volume":"71","author":"E Wright","year":"2008","unstructured":"Wright E, Brew B, Arayawichanont A, Robertson K, Samintharapanya K, Kongsaengdao S et al (2008) Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region. Neurology 71(1):50\u201356","journal-title":"Neurology"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-015-0374-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13365-015-0374-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-015-0374-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T18:23:56Z","timestamp":1718043836000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13365-015-0374-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,25]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["374"],"URL":"https:\/\/doi.org\/10.1007\/s13365-015-0374-7","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,25]]}}}